Changes in systemic immune-inflammation index (SII) predict the prognosis of patients with hepatitis B-related hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors
- DOI
- 10.1007/s12094-024-03596-0
- Published
- 2024-08-17
- Container
- Clinical and Translational Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12094-024-03596-0,
title = {Changes in systemic immune-inflammation index (SII) predict the prognosis of patients with hepatitis B-related hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors},
author = {Yang Yao and Minyue Zhang and Di Liu and Xiaoni Liu and Quanwei Li and Xiaojun Wang},
year = {2024},
journal = {Clinical and Translational Oncology},
doi = {10.1007/s12094-024-03596-0},
url = {https://doi.org/10.1007/s12094-024-03596-0}
}RIS
TY - JOUR TI - Changes in systemic immune-inflammation index (SII) predict the prognosis of patients with hepatitis B-related hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors AU - Yang Yao AU - Minyue Zhang AU - Di Liu AU - Xiaoni Liu AU - Quanwei Li AU - Xiaojun Wang PY - 2024 JO - Clinical and Translational Oncology DO - 10.1007/s12094-024-03596-0 UR - https://doi.org/10.1007/s12094-024-03596-0 ER -
APA
Yao, Y., Zhang, M., Liu, D., Liu, X., Li, Q., & Wang, X. (2024). Changes in systemic immune-inflammation index (SII) predict the prognosis of patients with hepatitis B-related hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03596-0
Source records
- crossref · retrieved 2026-09-27T09:08:07.222Z